Adapted systemic inflammation score as a novel prognostic marker for esophageal squamous cell carcinoma patients

Abstract Background The adapted systemic inflammation score (aSIS), calculated from serum albumin and the lymphocyte‐to‐monocyte ratio, has been reported to be a novel prognostic marker for some types of cancers. However, the prognostic impact of aSIS in patients with esophageal squamous cell carcin...

Full description

Bibliographic Details
Main Authors: Daichi Nomoto, Yoshifumi Baba, Takahiko Akiyama, Kazuo Okadome, Masaaki Iwatsuki, Shiro Iwagami, Yuji Miyamoto, Naoya Yoshida, Masayuki Watanabe, Hideo Baba
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Annals of Gastroenterological Surgery
Subjects:
Online Access:https://doi.org/10.1002/ags3.12464